Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
We examine how AI is changing the future of work — and how, in many ways, that future is already here. Every tech company you can think of is jumping on the generative AI bandwagon and touting new ...
Here is Deadline's annual list of premiere dates for new and returning TV series. Updated daily, the roster covers hundreds of broadcast, cable and streaming programs debuting throughout 2026, many ...
Click to open image viewer. CC0 Usage Conditions ApplyClick for more information. IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage ...
Did you know that you can now use Windows Update to reinstall your current Windows 11 version without losing data? Yes, this new feature lets you reinstall your current Windows 11 version using ...
Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results